These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 30425649)

  • 21. Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues.
    Longo M; Scappaticcio L; Cirillo P; Maio A; Carotenuto R; Maiorino MI; Bellastella G; Esposito K
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
    Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
    Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetic cardiomyopathy].
    Okoshi K; Guimarães JF; Di Muzio BP; Fernandes AA; Okoshi MP
    Arq Bras Endocrinol Metabol; 2007 Mar; 51(2):160-7. PubMed ID: 17505622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
    Huynh K; Bernardo BC; McMullen JR; Ritchie RH
    Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress: a key contributor to diabetic cardiomyopathy.
    Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
    Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Western diet given to healthy rats mimics the human phenotype of diabetic cardiomyopathy.
    Verboven M; Deluyker D; Ferferieva V; Lambrichts I; Hansen D; Eijnde BO; Bito V
    J Nutr Biochem; 2018 Nov; 61():140-146. PubMed ID: 30245335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetic cardiomyopathy: concept, heart function, and pathogenesis].
    Codinach Huix P; Freixa Pamias R
    An Med Interna; 2002 Jun; 19(6):313-20. PubMed ID: 12152393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.
    Toedebusch R; Belenchia A; Pulakat L
    Front Physiol; 2018; 9():453. PubMed ID: 29773993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy.
    Watanabe K; Thandavarayan RA; Gurusamy N; Zhang S; Muslin AJ; Suzuki K; Tachikawa H; Kodama M; Aizawa Y
    Acta Physiol Hung; 2009 Sep; 96(3):277-87. PubMed ID: 19706371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diabetic cardiomyopathy].
    Huang YQ; Wang X; Kong W
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
    Mahmoud AM
    Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy.
    Evangelista I; Nuti R; Picchioni T; Dotta F; Palazzuoli A
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms.
    Salvatore T; Pafundi PC; Galiero R; Albanese G; Di Martino A; Caturano A; Vetrano E; Rinaldi L; Sasso FC
    Front Med (Lausanne); 2021; 8():695792. PubMed ID: 34277669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response.
    Kaur N; Guan Y; Raja R; Ruiz-Velasco A; Liu W
    Front Physiol; 2021; 12():694864. PubMed ID: 34234695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic Cardiomyopathy: An Immunometabolic Perspective.
    Mishra PK; Ying W; Nandi SS; Bandyopadhyay GK; Patel KK; Mahata SK
    Front Endocrinol (Lausanne); 2017; 8():72. PubMed ID: 28439258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic Cardiomyopathy; Summary of 41 Years.
    Yilmaz S; Canpolat U; Aydogdu S; Abboud HE
    Korean Circ J; 2015 Jul; 45(4):266-72. PubMed ID: 26240579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs: A Critical Regulator and a Promising Therapeutic and Diagnostic Molecule for Diabetic Cardiomyopathy.
    Mathur P; Rani V
    Curr Gene Ther; 2021; 21(4):313-326. PubMed ID: 33719971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.